| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/16/2007 | CA2219882C Immunochemical-based test device with lift and twist specimen pull tab |
| 01/15/2007 | CA2552130A1 Methods of detecting gaseous component levels in a breath |
| 01/11/2007 | WO2007006031A2 Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them |
| 01/11/2007 | WO2007006016A2 Mammalian sour/ acid taste and csf receptor genes, polypeptides and assays |
| 01/11/2007 | WO2007005955A2 Anti-il-23 antibodies, compositions, methods and uses |
| 01/11/2007 | WO2007005946A2 Detection of rho proteins |
| 01/11/2007 | WO2007005881A2 Calibration system for use with lateral flow assay test strips |
| 01/11/2007 | WO2007005867A2 Compositions and methods for providing a graded response in a protein |
| 01/11/2007 | WO2007005865A2 Novel bioassay system using a nanoparticle |
| 01/11/2007 | WO2007005854A2 Modular sample processing apparatus kits and modules |
| 01/11/2007 | WO2007005782A2 In-situ water analysis method and system |
| 01/11/2007 | WO2007005690A1 Methods of determining pharmacokinetics of targeted therapies |
| 01/11/2007 | WO2007005627A2 Tuberculosis antigen detection assays and vaccines |
| 01/11/2007 | WO2007005559A2 Tat-005 and methods of assessing and treating cancer |
| 01/11/2007 | WO2007005502A2 Methods and compositions for treating diseases targeting cdcp1 |
| 01/11/2007 | WO2007005443A2 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors |
| 01/11/2007 | WO2007005426A2 Methods and kits for the diagnosis of acute coronary syndrome |
| 01/11/2007 | WO2007005244A1 Henipavirus receptor and uses thereof |
| 01/11/2007 | WO2007005222A2 Cyanine dyes and methods of use in biological applications |
| 01/11/2007 | WO2007005027A1 Identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha |
| 01/11/2007 | WO2007005024A1 Method and apparatus for measuring the density of one component in a multi-component flow |
| 01/11/2007 | WO2007004985A1 Nucleic acid biosensor with photoelectrochemical amplification |
| 01/11/2007 | WO2007004897A1 Device and method for analysing fluids in a tank |
| 01/11/2007 | WO2007004873A1 Device and method for determining the concentration of a substance |
| 01/11/2007 | WO2007004748A1 Nucleic acid capable of binding to immunoglobulin g and use thereof |
| 01/11/2007 | WO2007004693A1 Probe-immobilized carrier storing manufacturing condition data and manufacturing method and apparatus thereof, detecting method of target substance by use of the probe-immobilized carrier, and measuring apparatus, recording medium, kit and system for use in the detecting method |
| 01/11/2007 | WO2007004692A1 Prophylactic/therapeutic agent and diagnostic agent for non-small cell lung cancer |
| 01/11/2007 | WO2007004687A1 A method for separating target component using magnetic nanoparticles |
| 01/11/2007 | WO2007004659A1 Method for procyanidin analysis |
| 01/11/2007 | WO2007004600A2 Target substance-capturing body, device for capturing target substance, and instrument, kit and method for detecting target substance by use of them |
| 01/11/2007 | WO2007004526A2 Identification of compounds modulating the smyd3 transferase for the treatment of cancer |
| 01/11/2007 | WO2007004361A1 Transfected non-human mammal and method for monitoring toxic chemical substance in environment using the same |
| 01/11/2007 | WO2007004353A1 Indication composition for surgical instrument cleaning evaluation |
| 01/11/2007 | WO2007004341A1 Rna-binding peptide |
| 01/11/2007 | WO2007004337A1 White hair development model animal, method for establishing white hair development model animal, method for passage of white hair development model animal, method for study on white hair development, screening method for white hair development-control means, and composition for control of white hair development |
| 01/11/2007 | WO2007004288A1 Method for labeling/separation of cells and reagent for labeling/separation of cells |
| 01/11/2007 | WO2007004275A1 Health control check method and system |
| 01/11/2007 | WO2007004103A1 Cartridge for automated medical diagnostics |
| 01/11/2007 | WO2007003950A1 Core 2 beta(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis |
| 01/11/2007 | WO2007003944A2 Compounds for imaging and therapy |
| 01/11/2007 | WO2007003941A1 Modulation of autophagy by calpain inhibition |
| 01/11/2007 | WO2007003720A1 Low wetting hysteresis hydrophobic surface coating, method for depositing same, microcomponent and use |
| 01/11/2007 | WO2007003670A1 Fibrosis markers |
| 01/11/2007 | WO2007003637A1 Resonator-detector for the acoustic identification of particles in a gaseous atmosphere and method for the design thereof |
| 01/11/2007 | WO2007003420A1 Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody |
| 01/11/2007 | WO2007003415A1 Method for the selective detection of pathological protein depositions |
| 01/11/2007 | WO2007003399A2 Electrode assembly, use thereof, and method for the production thereof |
| 01/11/2007 | WO2007003398A2 Electrode assembly, use thereof, and method for the production thereof |
| 01/11/2007 | WO2007003344A2 Device for quantitative analysis of a metabolite profile |
| 01/11/2007 | WO2007003327A1 Carboxylated latex particles |
| 01/11/2007 | WO2007003154A2 Method and device for determining the quality of plant products |
| 01/11/2007 | WO2007003090A1 A composition instead of positive sera used as control in diagnostic agent and its application |
| 01/11/2007 | WO2007003041A1 Methods of isolating cells and generating monoclonal antibodies |
| 01/11/2007 | WO2007002994A1 Soil moisture sensor |
| 01/11/2007 | WO2006127695A3 Ascorbic acid conjugates |
| 01/11/2007 | WO2006123189A3 Device for detection and measurement of a target compound such as a food toxin |
| 01/11/2007 | WO2006123154A3 Improved methods and kits for detecting an enzyme capable of modifying a nucleic acid |
| 01/11/2007 | WO2006122733A3 Application of a reagent to a matrix material |
| 01/11/2007 | WO2006117161A3 New labelling strategies for the sensitive detection of analytes |
| 01/11/2007 | WO2006113766A3 Methods for diagnosing treating neuroendocrine cancer |
| 01/11/2007 | WO2006111586B1 Method for the in vitro determination of the degree of methylation of the line-1 promoter |
| 01/11/2007 | WO2006110589A3 Gammaretrovirus associated with cancer |
| 01/11/2007 | WO2006109274A3 Error detection in analyte measurements based on measurement of system resistance |
| 01/11/2007 | WO2006102653A3 Methods and compositions for treating insulin resistance and obesity-induced diseases |
| 01/11/2007 | WO2006094073A3 Functional bioluminescence energy resonance transfer (bret) assay to screen, identify and characterize receptor tyrosine kinase ligands |
| 01/11/2007 | WO2006089212A3 Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
| 01/11/2007 | WO2006085033A3 Pharmaceutical compositions for the treatment of prostate cancer |
| 01/11/2007 | WO2006084142A3 Dyslipoproteinemia associated with venous thrombosis |
| 01/11/2007 | WO2006084068A3 Method of adjusting the working range of a multi-analyte assay |
| 01/11/2007 | WO2006083936A3 Anti-ephb2 antibodies and methods using same |
| 01/11/2007 | WO2006083355A3 Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics |
| 01/11/2007 | WO2006083262A3 Method for enhanced accuracy in predicting peptides elution time using liquid separations or chromatography |
| 01/11/2007 | WO2006082313A3 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 01/11/2007 | WO2006074360A3 Apolipoprotein a-ii isoform as a biomarker for prostate cancer |
| 01/11/2007 | WO2006060922A3 Microfluidic microarray assemblies and methods of manufacturing and using same |
| 01/11/2007 | WO2006053972A3 Silanizing agents comprising a saccharide end group and uses thereof, such as for the functionalization of solid supports |
| 01/11/2007 | WO2006052489A3 T cell proteins and nucleotides encoding the same |
| 01/11/2007 | WO2006047791A3 Dna-templated combinatorial library device and method for use |
| 01/11/2007 | WO2006026601A3 Homogeneous enzyme immunoassay for oral fluid |
| 01/11/2007 | WO2005124358A3 Diagnosis and treatment of siglec-6 associated diseases |
| 01/11/2007 | WO2005100588A3 Protein-protein interactions for pharmacological profiling |
| 01/11/2007 | WO2005098434A3 RM2 ANTIGEN (ß1,4-GALNAC-DISIALYL-LC4) AS PROSTATE CANCER-ASSOCIATED ANTIGEN |
| 01/11/2007 | WO2005090990A3 Cytotoxicity assay |
| 01/11/2007 | WO2005042761A3 Biomarkers for amyotrophic lateral sclerosis |
| 01/11/2007 | WO2003083057A3 Adipocytes and uses thereof |
| 01/11/2007 | US20070011757 Transgenic rodents as animal models for modulation of B1 bradykinin receptor protein |
| 01/11/2007 | US20070010954 Inspection system and apparatus |
| 01/11/2007 | US20070010953 Auto-Analysis Framework for Sequence Evaluation |
| 01/11/2007 | US20070010949 Crystal structures of YHHF polypeptides |
| 01/11/2007 | US20070010948 G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model |
| 01/11/2007 | US20070010662 VGF fusion polypeptides |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/11/2007 | US20070010476 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010468 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 01/11/2007 | US20070010448 Drug targets in Candida albicans |
| 01/11/2007 | US20070010443 Monitoring and modulating HGF/HGFR activity |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010433 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |